Cited by

• Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization-Lancet Neurology Commission.

  Feigin VL, Owolabi MO; World Stroke Organization–Lancet Neurology Commission Stroke Collaboration Group. Feigin VL, et al. Lancet Neurol. 2023 Dec;22(12):1160-1206. doi: 10.1016/S1474-4422(23)00277-6. Epub 2023 Oct 9. Lancet Neurol. 2023. PMID: 37827183 Free PMC article. Review.
• Establishment of a forward primers-superposed amplification analysis for accurate aspirin pharmacogenomic measurement.

  Li CY, Yang P, Zheng J, Zhang J, Liu YQ, Liu XQ, Hu Y, Lan WJ. Li CY, et al. Sci Rep. 2024 Jan 9;14(1):880. doi: 10.1038/s41598-024-51458-0. Sci Rep. 2024. PMID: 38195704 Free PMC article.
• [The polypill in cardiovascular prevention: successful through simplification? : New study results on the benefit of the polypill strategy in primary and secondary prevention].

  Despang P, Schikora M, Doehner W. Despang P, et al. Inn Med (Heidelb). 2023 Jun;64(6):598-604. doi: 10.1007/s00108-023-01506-0. Epub 2023 May 25. Inn Med (Heidelb). 2023. PMID: 37227456 Free PMC article. Review. German.
• Polypill Therapy for Cardiovascular Disease Prevention and Combination Medication Therapy for Hypertension Management.

  Narita K, Hoshide S, Kario K. Narita K, et al. J Clin Med. 2023 Nov 22;12(23):7226. doi: 10.3390/jcm12237226. J Clin Med. 2023. PMID: 38068278 Free PMC article. Review.
• Twenty years on from the introduction of the high risk strategy for stroke and cardiovascular disease prevention: a systematic scoping review.

  Feigin VL, Martins SC, Brainin M, Norrving B, Kamenova S, Giniyat A, Kondybayeva A, Aldyngurov DK, Bapayeva M, Zhanuzakov M, Hankey GJ. Feigin VL, et al. Eur J Neurol. 2024 Mar;31(3):e16157. doi: 10.1111/ene.16157. Epub 2023 Nov 27. Eur J Neurol. 2024. PMID: 38009814 Free PMC article.